Update information
January 2014: minor maintenance.
April 2013: The wording of the recommendation describing the patient access scheme (see section 1.1) has been amended to make it clear which scheme is being referred to.
October 2023: The wording of the recommendation describing the patient access scheme (see section 1.1) and section 2.4 have been updated to include procurement information about ranibizumab biosimilars.
ISBN 978-1-4731-5499-5